Bml 259

Bml 259 is a potent inhibitor of Cdk5/p25. It also inhibits Cdk2/cyclin E.

267654-00-2

N- (5-Isopropylthiazol-2-yl) phenylacetamide

41116105

Inhibitor

Synthetic

Cell Signaling | Cancer | Apoptosis | Cancer Growth Inhibitors | Tyrosine Kinase Inhibitors

≥98% (TLC)

0.025

White solid

Soluble in DMSO (30 mg/ml), dimethyl formamide (30 mg/ml) or 100% ethanol (0.25 mg/ml)

C14H16N2OS

260.4

Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

1. Kaźmierczak A., Czapski G.A., Adamczyk A., Gajkowska B., & Strosznajder J.B. (2011) Neurochem. Int. 58(2): 206–214.